User login
Comparison of Micronized Tretinoin Gel 0.05% and Tretinoin Gel Microsphere 0.1% in Young Adolescents with Acne: A Post Hoc Analysis of Efficacy and Tolerability Data
Article Type
Changed
Thu, 01/10/2019 - 12:23
Display Headline
Comparison of Micronized Tretinoin Gel 0.05% and Tretinoin Gel Microsphere 0.1% in Young Adolescents with Acne: A Post Hoc Analysis of Efficacy and Tolerability Data
Article PDF
Issue
Cutis - 87(6)
Publications
Topics
Page Number
305,306,307,308,309,310
Sections
Article PDF
Article PDF
Issue
Cutis - 87(6)
Issue
Cutis - 87(6)
Page Number
305,306,307,308,309,310
Page Number
305,306,307,308,309,310
Publications
Publications
Topics
Article Type
Display Headline
Comparison of Micronized Tretinoin Gel 0.05% and Tretinoin Gel Microsphere 0.1% in Young Adolescents with Acne: A Post Hoc Analysis of Efficacy and Tolerability Data
Display Headline
Comparison of Micronized Tretinoin Gel 0.05% and Tretinoin Gel Microsphere 0.1% in Young Adolescents with Acne: A Post Hoc Analysis of Efficacy and Tolerability Data
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Article Type
Changed
Thu, 01/10/2019 - 12:15
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Article PDF
Issue
Cutis - 82(2)
Publications
Topics
Page Number
143-150
Sections
Article PDF
Article PDF
Issue
Cutis - 82(2)
Issue
Cutis - 82(2)
Page Number
143-150
Page Number
143-150
Publications
Publications
Topics
Article Type
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
A Center's Callosities
Article Type
Changed
Thu, 01/10/2019 - 11:50
Display Headline
A Center's Callosities
Article PDF
Issue
Cutis - 67(2)
Publications
Page Number
141-142
Article PDF
Article PDF
Issue
Cutis - 67(2)
Issue
Cutis - 67(2)
Page Number
141-142
Page Number
141-142
Publications
Publications
Article Type
Display Headline
A Center's Callosities
Display Headline
A Center's Callosities
Disallow All Ads
Article PDF Media
Document